This talk will focus on the complex management of women with epilepsy during their pregnancy, in order to optimize outcomes for both the mother and baby. The talk will focus on balancing the risks of uncontrolled seizures and the risks of anti-seizure medications. The talk will cover the risks of uncontrolled seizures; the risks of anti-seizure medication exposure to the foetus; and suggestions on management to optimize outcomes.
With regards to risks of uncontrolled seizures, the talk will focus on the maternal and fetal risks; the impact of pregnancy on seizure control; and the impact of anti-seizure medication pharmacokinetics on seizure control.
In terms of risks of anti-seizure medications, the talk will focus on effects on fetal growth; major congenital malformations; and developmental and behavioural outcomes.
Finally, the talk with discuss suggestions for management, in order to optimize outcomes during the pre-conception period, pregnancy, and the post-partum period.